Humacyte Inc.

01/07/2024 | Press release | Distributed by Public on 01/07/2024 12:10

Humacyte Acellular Tissue Engineered Vessel (ATEV™) Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for Patients with Advanced Peripheral Artery[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.